CRO Services Center (Phase I-III)

CRO Services (Phase I-III) Partners

Clinical Trials are required for drug therapies to receive regulatory approval.

A Phase 1 trial is the first to involve human subjects, and their objective is to determine the highest does of a treatment that can be safely administered to patients. A Phase 2 trial is conducted on a small number of patients to determine if the drug is effective. If the Phase 1 and Phase 2 trials are successful, a larger Phase 3 trial is conducted to gather data to present to the FDA. In a Phase 3 trial a drug is often tested against a placebo or the current standard of care. Clinical trials are expensive and time consuming, and they require expertise in many areas. Sponsors need to perform study startup (which includes site selection and patient recruitment), manage and oversee the trial, and collect and analyze trial data. All of these operations can be performed by a CRO.

How can we help?

Looking for help with your Phase I-III project? If you're searching for information or a supplier, let Clinical Leader lend you a hand.

Submit A Question

CRO Services Center (Phase I-III) Provider - Bioforum the Data Masters Inc.
Bioforum the Data Masters Inc.

Bioforum is a data-focused contract research organization (CRO), serving clients worldwide in optimizing the collection, standardization, and reporting of clinical research data. We strive to consistently improve and innovate data processes, enabling the most efficient data submissions for our clients across the life sciences industry worldwide. Our multidisciplinary team provides in-depth expertise and delivers high-quality solutions, including medical writing, data management, biostatistics and statistical programming.

CRO Services Center (Phase I-III) Provider - Biorasi
Biorasi

Biorasi is an award-winning contract research organization accelerating drug and device clinical development for life sciences companies around the world. Since 2002, Biorasi has achieved success in bringing innovative therapies to market for our sponsors. Biorasi solves the problem of poor clinical trial performance with better patient recruitment, powerful data insights, and operational excellence. We deliver faster, higher quality clinical trials.

Capabilities

CRO Services Center (Phase I-III) Provider - Cmed Clinical Research Services
Cmed Clinical Research Services

Where Technology Meets Expertise. No other CRO is better prepared to support the future of clinical trials. Technology-led, user-focused and with expertise in oncology, cell & gene therapy, rare diseases, data science and analytics, we pioneered next generation trials. As the industry continues to undergo seismic change, our 20 years of expertise enables us to embrace radical disruption and transform the clinical trials landscape for the benefit of patients.

Capabilities


Have questions about selecting the right Phase I-III service provider?

The Clinical Leader team can help. We'll match your needs with the right companies.

Contact us via email for assistance.


CRO Services Center (Phase I-III) Provider - CMIC Group
CMIC Group

CMIC was founded in 1992 as the first CRO in Japan. To enable pharmaceutical companies to develop better medicine sooner, we expanded our solutions to include contract development and manufacturing, site support, and market solutions, supporting global companies to bring highly desired treatments to the Japanese market, to consult and conduct Asia clinical trials, or to bridge drug development and manufacturing needs between the US and Japan.

Capabilities

CRO Services Center (Phase I-III) Provider - Harbor Clinical
Harbor Clinical

Harbor Clinical is a women-owned clinical research services firm with headquarters in the Boston biotech area. As a Functional Service Provider (FSP) offering Staff Augmentation, Consulting, and Single-Service resourcing models, Harbor Clinical's mission is based on the goal of forging innovative partnerships, with sponsors and employees, built on a bedrock of communication and transparency.

CRO Services Center (Phase I-III) Provider - inSeption Group
inSeption Group

inSeption distinguishes people as the most impactful variable in the outsourcing equation. Our path-breaking model attracts biopharma companies who demand a partner that shares in their drive to conduct impeccable development and will provide quality and dependable clinical solutions. We offer full outsourcing, consulting services, and functional service provider (FSP) solutions.

Capabilities


CRO Services Center (Phase I-III) Provider - IQVIA Biotech
IQVIA Biotech

IQVIA Biotech delivers flexible clinical development solutions designed to help biotech and emerging biopharma companies get treatments to patients. When you partner with our clinical team, you gain expertise from two decades of running clinical trials exclusively for biotech companies. We understand the unique challenges, hurdles, and opportunities you face. From strategy and trial design to execution, we draw on this experience to put together the right solution for you.

Capabilities

CRO Services Center (Phase I-III) Provider - IQVIA Integrated Global Compliance
IQVIA Integrated Global Compliance

IQVIA Integrated Global Compliance offers a complete lifecycle approach that brings together safety, regulatory, quality, and medical information to transform how life sciences companies sustain compliance and how compliance functions perform better together.

By integrating services, technology, and analytics, we can help bring together disparate compliance functions, resulting in heightened patient safety, improved compliance performance, and proactive insights power by IQVIA Connected Intelligence.

CRO Services Center (Phase I-III) Provider - IQVIA Research & Development Solutions
IQVIA Research & Development Solutions

IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. IQVIA creates intelligent connections to deliver powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 70,000 employees, IQVIA conducts operations in more than 100 countries.


CRO Services Center (Phase I-III) Provider - KPS Life
KPS Life

Founded in 2006, KPS Life is a standalone functional service provider (FSP) that offers global functional clinical trial outsourcing services to sponsors. Its services include clinical monitoring, clinical oversight, clinical trial management, data management, eTMF and document management, vendor qualification, and medical writing. KPS Life is uniquely devoted to providing customized, outsourced clinical solutions to pharmaceutical and biotech customers of all sizes across all stages of clinical trials.

Capabilities

CRO Services Center (Phase I-III) Provider - Novotech
Novotech

Novotech is the leading Asia-Pacific biotech specialist CRO with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, and drug development consulting services. It has accumulated experience in over 3,700 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biopharmaceutical clients conducting clinical trials in Asia, the US and globally.

CRO Services Center (Phase I-III) Provider - OCT Clinical
OCT Clinical

OCT is the leading contract research organization in Russia. Since 2005, OCT's team has conducted over 300 clinical trials in 29 therapeutic areas in Eastern Europe and the CIS region. Our team of 150+ clinical professionals provides a full range of high-quality CRO services for Phase I-IV and BE studies, with therapeutic expertise in oncology, infectious disease, and all major therapeutic indications.


CRO Services Center (Phase I-III) Provider - Precision ADVANCE
Precision ADVANCE

Precision ADVANCE is a collection of interconnected services and complementary teams uniquely focus on the complexities of clinical, regulatory, manufacturing, and commercial needs to successfully bring cell or gene therapies to market. Learn more about how we accelerate clinical development with Precision for Medicine, optimize next-gen manufacturing with Project Farma and drive commercial success with Precision Value & Health.

Capabilities

CRO Services Center (Phase I-III) Provider - Premier Research
Premier Research

Premier Research recognizes that when an emerging biotech is built around a single asset, focus and flexibility are critical to success. And, since many of our customers require additional infrastructure, we fill in resourcing gaps to help their product reach the patient faster. We are a mid-size CRO and offer strategies that are customized for each program, with tailored processes designed to meet highly specific needs.

Capabilities

CRO Services Center (Phase I-III) Provider - Veristat
Veristat

Veristat, a global clinical research organization (CRO), enables sponsors to solve the unique and complex challenges associated with accelerating therapies through clinical development to regulatory approval. With more than 26 years' experience in clinical trial planning and execution, Veristat is equipped to support any development program. Our team has prepared over 100 marketing applications for approval with global regulatory authorities in the last 10 years alone.

Capabilities